CRO QPS Qualitix has continued its expansion in Asia with a new office in China.
The office in Beijing's Chao Yang District will provide late-phase clinical trial services, including site management , biostatistics, data management, medical writing and regulatory affairs support.
General manager Vincent Yen said the office “will leverage QPS’ quality and training systems to offer customized, high-quality drug development solutions best suited for local Chinese biopharma, as well as global biopharma’s local affiliates.”
QPS has been building is presence in Asia since even before it acquired a majority stake in Qualitix Clinical Research in March last year . The process began in January 2011 when it invested in Indian bioanalytical services firm Bioserve Clinical Research .
The following month QPS bought the Taiwan Center of Toxicology’s preclinical services unit .